Autolus Therapeutics plc Stock News

Shares of Autolus Therapeutics Ltd – (NASDAQ:AUTL) have received a consensus recommendation of “Buy” from the seven ratings firms that are covering the company, Marketbeat Ratings reports. One e

Goldman Sachs Group Inc. lessened its stake in Autolus Therapeutics Ltd – (NASDAQ:AUTL) by 55.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and

Wall Street brokerages expect Autolus Therapeutics Ltd – (NASDAQ:AUTL) to post sales of $1.15 million for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Autolus Ther

A look at the shareholders of Autolus Therapeutics plc (NASDAQ:AUTL) can tell us which group is most powerful...

Autolus Therapeutics (NASDAQ:AUTL) was upgraded by research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Thursday, BidAskClub reports. Oth

Research analysts at Mizuho initiated coverage on shares of Autolus Therapeutics (NASDAQ:AUTL) in a research note issued to investors on Tuesday, MarketBeat.com reports. The firm set a “buy” ratin

Adaptimmune (NASDAQ:ADAP) initiated with Neutral rating and $3 (17% downside risk) price target at Mizuho Securities.Autolus Therapeutics (NASDAQ:AUTL) initiated with Buy rating and $18 (90% upside) p

In a report released today, Mara Goldstein from Mizuho Securities initiated coverage with a Buy rating on Autolus Therapeutics (AUTL) and a price target

In a report released today, Mara Goldstein from Mizuho Securities initiated coverage with a Buy rating on Autolus Therapeutics (AUTL

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfenex (PFNX) and Autolus Therapeutics (AUTL) with bullish

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfenex (PFNX

Autolus Therapeutics (NASDAQ:AUTL) and PDL BioPharma (NASDAQ:PDLI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength o

Autolus Therapeutics PLC:

Autolus Therapeutics plc (AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer, announces that the U.S. Food and Drug

Ladenburg Thalmann Financial Services Inc. acquired a new position in Autolus Therapeutics Ltd – (NASDAQ:AUTL) in the fourth quarter, according to the company in its most recent Form 13F filing with